NCT04944160View on ClinicalTrials.gov

Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

May 15, 2021

Study Completion Date

June 28, 2021

Conditions
RSV Infection
Interventions
OTHER

Medical records analysis

To review of medical records to describe diagnosis and severity of the disease.

OTHER

Comparison of cohorts

To compare pre and post Covid-19 epidemics in terms of numbers of admissions, and proportion of severe disease.

Trial Locations (1)

69500

Groupement Hospitalier EST - Hospices Civils de Lyon, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04944160 - Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic | Biotech Hunter | Biotech Hunter